COVID-19 and MIS-C treatment in children—results from an international survey

Children have been mostly excluded from COVID-19 clinical trials, and, as a result, most medicines approved for COVID-19 have no pediatric indication. In addition, access to COVID-19 therapeutics remains limited. Collecting physicians’ experiences with off-label use of therapeutics is important to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Donà, Daniele, Minotti, Chiara, Masini, Tiziana, Penazzato, Martina, Van Der Zalm, Marieke M., Judd, Ali, Giaquinto, Carlo, Lallemant, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640428/
https://www.ncbi.nlm.nih.gov/pubmed/37672062
http://dx.doi.org/10.1007/s00431-023-05179-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640428/
https://www.ncbi.nlm.nih.gov/pubmed/37672062
http://dx.doi.org/10.1007/s00431-023-05179-7

Ejemplares similares